Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing. 

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

The procedure, which lasted roughly two and half hours, was performed on a 16-year-old patient with end-stage heart failure. 

The cloud-based platform identifies and measures cardiac structures in CT scans.

These companies were already part of the Johnson & Johnson family, but they had still retained their previous brand names. Now, each one is officially going by Johnson & Johnson MedTech. 

Pedro Martinez-Clark, MD, an interventional cardiologist and founder of Amavita Heart and Vascular Health, explains the health disparities he encounters that block the delivery of care in certain parts of Miami.

The sensors of certain FreeStyle Libre 3 devices are producing inaccurate glucose readings and should not be used. Two patient injuries have been reported. Abbott first reported the problem in July.